|Minimum Order Quantity||1 Vial|
|Use||Commercial, Clinical, Hospital, Personal|
|Dose/Strength (ex. 1 mg or 1 ml)||2mg|
|Usage||Clinical, Personal, Hospital|
What is Bortezomib- injection?
Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma.
Bortezomib Indications / Bortezomib Uses
In multiple myeloma.
Bortezomib Adverse Reactions / Bortezomib Side Effects
Asthenic conditions; pyrexia; GI disturbances, anorexia; dehydration; peripheral neuropathy; thrombocytopenia, neutropenia, anemia; hypotension; cardiac disorders; bone and body pain; cough, dyspnoea; rash, oedema; hypersensitivity reactions; painful or difficult urination.
Pneumonia, pyrexia, diarrhea, vomiting, dehydration and nausea.
Hepatic or renal impairment; history of syncope, orthostatic hypotension; dehydration. Impairs ability to drive or operate machinery. Monitor for symptoms of peripheral neuropathy. Monitor closely the blood glucose levels in patients receiving oral ant diabetic agents.
Other Drug Interactions
Concurrent use of amiodarone, antiviral, isoniazid, nitrofurantoin, statins may increase the chance of peripheral neuropathy. Concurrent use of antihypertensive increases the chance of hypotension.
|Minimum Order Quantity||1 Unit|
|Usage||Commercial, Personal, Hospital, Clinical|
|Dose||Bortezomib 3.5 Mg|
Leveraging upon our advanced production facility we provide a super quality Bortezomib for Injection 3.5 mg. The offered injections are processed with superb quality ingredients as per with internationally accepted standards. It helps to slow down the growth of cancerous cells in the body and is used for the treatment of multiple myeloma and mantle cell lymphoma. Moreover, the provided injection is clinically tested against variegated quality parameters to deliver an effective range at patrons end.